Richard A. Graham, SVP, Development at Theravance Biopharma, Inc. (TBPH), sold 7,500 shares at $19.47 ($146K) on 2020-12-14, disclosed to the SEC on 2020-12-16.
Open-market sale of $146k TBPH by SVP, Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| TBPH | SELL | 2023-09-18 | $25K | — | Filing → |
| TBPH | SELL | 2023-08-15 | $23K | — | Filing → |
| TBPH | SELL | 2023-07-18 | $23K | — | Filing → |